TDB Provides Rs 86 Crore in Funding for Vigor's AI Drug Development
What happened
The Technology Development Board (TDB) signed an agreement with Vigor, a Bengaluru-based company, to provide Rs 86 crore in financial support. This funding is part of a project called 'VIGOR--Moving AI-Discovered Molecules from the Lab to the Clinic,' which has a total cost of Rs 172 crore. The support will be provided through optionally convertible debt (OCD).
From indiatimes.com
Why it matters
The funding aims to advance four experimental drugs to technology readiness levels 4 to 6, requiring preclinical development and preparation for clinical trials. TDB stated that this initiative strengthens India's capabilities in biotechnology, pharmaceuticals, and AI-based healthcare innovation.
TDB disburses government RDI funds to support deeptech startups within Bengaluru's technology ecosystem.
From indiatimes.com
Who's involved
- TDBTechnology Development Board providing financial support
- VigorBengaluru-based company receiving funding for drug development
- Department of Science and TechnologyDepartment of Science and Technology under which TDB operates
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.
- VigorSpeculative
Vigor might accelerate core drug development and increase its research and development investment.
- IndiaSpeculative
India could strengthen its national capabilities in AI-based healthcare innovation through this investment.